Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 24;16(3):e0241875.
doi: 10.1371/journal.pone.0241875. eCollection 2021.

Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study

Brian E Dixon  1   2 , Kara K Wools-Kaloustian  3   4 , William F Fadel  5 , Thomas J Duszynski  1 , Constantin Yiannoutsos  5 , Paul K Halverson  6   7 , Nir Menachemi  2   6
Affiliations

Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study

Brian E Dixon et al. PLoS One. .

Abstract

Background: Prior studies examining symptoms of COVID-19 are primarily descriptive and measured among hospitalized individuals. Understanding symptoms of SARS-CoV-2 infection in pre-clinical, community-based populations may improve clinical screening, particularly during flu season. We sought to identify key symptoms and symptom combinations in a community-based population using robust methods.

Methods: We pooled community-based cohorts of individuals aged 12 and older screened for SARS-CoV-2 infection in April and June 2020 for a statewide prevalence study. Main outcome was SARS-CoV-2 positivity. We calculated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for individual symptoms as well as symptom combinations. We further employed multivariable logistic regression and exploratory factor analysis (EFA) to examine symptoms and combinations associated with SARS-CoV-2 infection.

Results: Among 8214 individuals screened, 368 individuals (4.5%) were RT-PCR positive for SARS-CoV-2. Although two-thirds of symptoms were highly specific (>90.0%), most symptoms individually possessed a PPV <50.0%. The individual symptoms most greatly associated with SARS-CoV-2 positivity were fever (OR = 5.34, p<0.001), anosmia (OR = 4.08, p<0.001), ageusia (OR = 2.38, p = 0.006), and cough (OR = 2.86, p<0.001). Results from EFA identified two primary symptom clusters most associated with SARS-CoV-2 infection: (1) ageusia, anosmia, and fever; and (2) shortness of breath, cough, and chest pain. Moreover, being non-white (13.6% vs. 2.3%, p<0.001), Hispanic (27.9% vs. 2.5%, p<0.001), or living in an Urban area (5.4% vs. 3.8%, p<0.001) was associated with infection.

Conclusions: Symptoms can help distinguish SARS-CoV-2 infection from other respiratory viruses, especially in community or urgent care settings where rapid testing may be limited. Symptoms should further be structured in clinical documentation to support identification of new cases and mitigation of disease spread by public health. These symptoms, derived from asymptomatic as well as mildly infected individuals, can also inform vaccine and therapeutic clinical trials.

PubMed Disclaimer

Conflict of interest statement

No authors have competing interests.

Figures

Fig 1
Fig 1. Results from the exploratory factor analysis of symptom clusters.
The figure summarizes the principal symptoms loading on each factor. The proportions represent individual loadings for each symptom onto its factor based on the factor’s correlation matrix.
Fig 2
Fig 2. Area under the curve (AUC) for logistic model fit to predict RT-PCR status given symptoms or patient demographics.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

  • Molecular Epidemiology of SARS-CoV-2 within Accra Metropolis Postlockdown.
    Aboagye FT, Annison L, Hackman HK, Acquah ME, Ashong Y, Owusu-Frimpong I, Egyam BC, Annison S, Osei-Adjei G, Antwi-Baffour S. Aboagye FT, et al. Adv Virol. 2024 Mar 29;2024:2993144. doi: 10.1155/2024/2993144. eCollection 2024. Adv Virol. 2024. PMID: 38584794 Free PMC article.
  • Factors associated with prolonged COVID-related PTSD-like symptoms among adults diagnosed with mild COVID-19 in Poland.
    Elkayam S, Łojek E, Sękowski M, Żarnecka D, Egbert A, Wyszomirska J, Hansen K, Malinowska E, Cysique L, Marcopulos B, Gawron N, Sobańska M, Gambin M, Holas P, Pluta A, Hyniewska S. Elkayam S, et al. Front Psychol. 2024 Mar 14;15:1358979. doi: 10.3389/fpsyg.2024.1358979. eCollection 2024. Front Psychol. 2024. PMID: 38550647 Free PMC article.
  • Barotrauma in patients with severe coronavirus disease 2019-retrospective observational study.
    Bajto P, Saric I, Bugarin JD, Delic N, Dosenovic S, Ilic D, Stipic SS, Duplancic B, Saric L. Bajto P, et al. J Thorac Dis. 2023 Oct 31;15(10):5297-5306. doi: 10.21037/jtd-23-677. Epub 2023 Sep 22. J Thorac Dis. 2023. PMID: 37969263 Free PMC article.
  • ANCOC Score to Predict Mortality in Different SARS-CoV-2 Variants and Vaccination Status.
    Candelli M, Sacco Fernandez M, Pignataro G, Merra G, Tullo G, Bronzino A, Piccioni A, Ojetti V, Gasbarrini A, Franceschi F. Candelli M, et al. J Clin Med. 2023 Sep 8;12(18):5838. doi: 10.3390/jcm12185838. J Clin Med. 2023. PMID: 37762779 Free PMC article.
  • Precision Medicine for More Oxygen (P4O2)-Study Design and First Results of the Long COVID-19 Extension.
    Baalbaki N, Blankestijn JM, Abdel-Aziz MI, de Backer J, Bazdar S, Beekers I, Beijers RJHCG, van den Bergh JP, Bloemsma LD, Bogaard HJ, van Bragt JJMH, van den Brink V, Charbonnier JP, Cornelissen MEB, Dagelet Y, Davies EH, van der Does AM, Downward GS, van Drunen CM, Gach D, Geelhoed JJM, Glastra J, Golebski K, Heijink IH, Holtjer JCS, Holverda S, Houweling L, Jacobs JJL, Jonker R, Kos R, Langen RCJ, van der Lee I, Leliveld A, Mohamed Hoesein FAA, Neerincx AH, Noij L, Olsson J, van de Pol M, Pouwels SD, Rolink E, Rutgers M, Șahin H, Schaminee D, Schols AMWJ, Schuurman L, Slingers G, Smeenk O, Sondermeijer B, Skipp PJ, Tamarit M, Verkouter I, Vermeulen R, de Vries R, Weersink EJM, van de Werken M, de Wit-van Wijck Y, Young S, Nossent EJ, Maitland-van der Zee AH; P4O2 consortium. Baalbaki N, et al. J Pers Med. 2023 Jun 28;13(7):1060. doi: 10.3390/jpm13071060. J Pers Med. 2023. PMID: 37511673 Free PMC article.
See all "Cited by" articles

References

    1. Centers for Disease Control and Prevention US. Symptoms of Coronavirus Atlanta: CDC; 2020 [cited 2020 May 5]. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
    1. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al.. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2020;94:91–5. Epub 2020/03/17. 10.1016/j.ijid.2020.03.017 . - DOI - PMC - PubMed
    1. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al.. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020. Epub 2020/04/30. 10.1111/joim.13091 . - DOI - PMC - PubMed
    1. Menni C, Valdes AM, Freidin MB, Sudre CH, Nguyen LH, Drew DA, et al.. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nature Medicine. 2020;26(7):1037–40. 10.1038/s41591-020-0916-2 - DOI - PMC - PubMed
    1. Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, et al.. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. The Cochrane database of systematic reviews. 2020;7(7):CD013665–CD. 10.1002/14651858.CD013665 . - DOI - PMC - PubMed

Publication types

MeSH terms

-